TAM
ATRA icon

Tiverton Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Tiverton Asset Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,147
Closed -$577K – 713
2019
Q2 		$577K Sell
1,147
-393
-26% -$277K 0.02% 351
2019
Q1 		$1.53M Sell
1,540
-1,499
-49% -$1.39M 0.07% 195
2018
Q4 		$2.64M Sell
3,039
-1,087
-26% -$1.01M 0.16% 110
2018
Q3 		$4.26M Buy
4,126
+633
+18% +$619K 0.21% 94
2018
Q2 		$3.21M Sell
3,493
-16
-0.5% -$17.2K 0.16% 109
2018
Q1 		$3.42M Buy
3,509
+2,831
+418% +$2.58M 0.24% 94
2017
Q4 		$306K Sell
678
-449
-40% -$166K 0.02% 304
2017
Q3 		$466K Sell
1,127
-138
-11% -$52K 0.03% 166
2017
Q2 		$443K Sell
1,265
-427
-25% -$165K 0.02% 172
2017
Q1 		$869K Hold
1,692
– – 0.04% 167
2016
Q4 		$600K Sell
1,692
-1,527
-47% -$647K 0.04% 179
2016
Q3 		$1.72M Sell
3,219
-4,936
-61% -$2.68M 0.14% 133
2016
Q2 		$6.75M Buy
8,155
+1,351
+20% +$648K 0.28% 97
2016
Q1 		$3.24M Sell
6,804
-601
-8% -$271K 0.11% 124
2015
Q4 		$4.89M Hold
7,405
– – 0.16% 112
2015
Q3 		$5.82M Sell
7,405
-1,600
-18% -$1.95M 0.13% 115
2015
Q2 		$11.9M Buy
9,005
+1,405
+18% +$1.61M 0.24% 100
2015
Q1 		$7.9M Buy
7,600
+3,600
+90% +$2.38M 0.16% 112
2014
Q4 		$2.67M Buy
+4,000
New +$2.44M 0.06% 127

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Tiverton Asset Management's ATRA Position: Q3 2019 in Review

Tiverton Asset Management sold out of Atara Biotherapeutics (ATRA) in Q3 2019, closing a stake of 1,147 shares — an estimated $577K sold.

Tiverton Asset Management first reported a position in ATRA in Q4 2014 and held it in 19 quarters. The position peaked at $11.9M in Q2 2015. 112 funds tracked by Wall St. Rank hold ATRA as of Q3 2019.

  • Tiverton Asset Management reported no remaining Atara Biotherapeutics position as of Q3 2019 after selling out during the quarter.
  • Tiverton Asset Management sold 1,147 Atara Biotherapeutics shares in Q3 2019, an estimated $577K.
  • Tiverton Asset Management first reported a position in Atara Biotherapeutics in Q4 2014 and held it in 19 quarters.
  • Tiverton Asset Management's Atara Biotherapeutics position peaked at $11.9M in Q2 2015.
  • 112 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.